CRS: BJMC
Position: Community Coordinator
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...